|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/25/16 Pacira BioSciences, Inc. 10-K 12/31/15 87:10M Workiva Inc Wde… FA01/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.15M
2: EX-10.57 Material Contract HTML 34K
3: EX-21.1 Subsidiaries List HTML 21K
4: EX-23.1 Consent of Experts or Counsel HTML 24K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 29K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 23K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 23K
15: R1 Document and Entity Information HTML 51K
16: R2 Consolidated Balance Sheets HTML 110K
17: R3 Consolidated Balance Sheets (Parenthetical) HTML 45K
18: R4 Consolidated Statements of Operations HTML 90K
19: R5 Consolidated Statements of Comprehensive Loss HTML 38K
20: R6 Consolidated Statements of Stockholders' Equity HTML 92K
(Deficit)
21: R7 Consolidated Statements of Cash Flows HTML 126K
22: R8 Description of Business HTML 29K
23: R9 Summary of Significant Accounting Policies HTML 157K
24: R10 Recent Accounting Pronouncements HTML 32K
25: R11 Inventories HTML 34K
26: R12 Fixed Assets HTML 43K
27: R13 Goodwill and Intangible Assets HTML 72K
28: R14 Accrued Expenses HTML 35K
29: R15 Debt HTML 83K
30: R16 Financial Instruments HTML 103K
31: R17 Stockholders' Equity HTML 42K
32: R18 Stock Plans HTML 169K
33: R19 Net Income (Loss) Per Share HTML 73K
34: R20 Income Taxes HTML 105K
35: R21 Other Employee Benefits HTML 26K
36: R22 Commercial Partners and Other Agreements HTML 40K
37: R23 Related Party Transactions HTML 34K
38: R24 Commitments and Contingencies HTML 49K
39: R25 Selected Quarterly Financial Data (Unaudited) HTML 68K
40: R26 Summary of Significant Accounting Policies HTML 228K
(Policies)
41: R27 Summary of Significant Accounting Policies HTML 117K
(Tables)
42: R28 Inventories (Tables) HTML 33K
43: R29 Fixed Assets (Tables) HTML 38K
44: R30 Goodwill and Intangible Assets (Tables) HTML 69K
45: R31 Accrued Expenses (Tables) HTML 35K
46: R32 Debt (Tables) HTML 55K
47: R33 Financial Instruments (Tables) HTML 95K
48: R34 Stockholders' Equity (Tables) HTML 32K
49: R35 Stock Plans (Tables) HTML 137K
50: R36 Net Income (Loss) Per Share (Tables) HTML 72K
51: R37 Income Taxes (Tables) HTML 69K
52: R38 Commitments and Contingencies (Tables) HTML 33K
53: R39 Selected Quarterly Financial Data (Unaudited) HTML 66K
(Tables)
54: R40 Summary of Significant Accounting Policies HTML 38K
(Details)
55: R41 Summary of Significant Accounting Policies Summary HTML 51K
of Significant Accounting Policies (Details 2)
56: R42 Summary of Significant Accounting Policies HTML 44K
(Details 3)
57: R43 Summary of Significant Accounting Policies HTML 42K
(Details 4)
58: R44 Inventories (Details) HTML 34K
59: R45 Fixed Assets (Details) HTML 52K
60: R46 Goodwill and Intangible Assets (Details) HTML 63K
61: R47 Goodwill and Intangible Assets (Details 2) HTML 52K
62: R48 Accrued Expenses (Details) HTML 36K
63: R49 Debt (Details) HTML 45K
64: R50 Debt (Details 2) HTML 155K
65: R51 Financial Instruments (Details) HTML 49K
66: R52 Financial Instruments (Details 2) HTML 55K
67: R53 Financial Instruments (Details 3) HTML 36K
68: R54 Stockholders' Equity (Details) HTML 44K
69: R55 Stockholders' Equity (Details 2) HTML 35K
70: R56 Stock Plans (Details) HTML 56K
71: R57 Stock Plans (Details 2) HTML 102K
72: R58 Stock Plans (Details 3) HTML 161K
73: R59 Net Income (Loss) Per Share (Details) HTML 64K
74: R60 Net Income (Loss) Per Share (Details 2) HTML 40K
75: R61 Income Taxes (Details) HTML 127K
76: R62 Income Taxes (Details 2) HTML 50K
77: R63 Other Employee Benefits (Details) HTML 25K
78: R64 Commercial Partners and Other Agreements (Details) HTML 45K
79: R65 Related Party Transactions (Details) HTML 55K
80: R66 Commitments and Contingencies (Details) HTML 55K
81: R67 Commitments and Contingencies (Details 2) HTML 30K
82: R68 Commitments and Contingencies (Details 3) HTML 37K
83: R69 Selected Quarterly Financial Data (Unaudited) HTML 49K
(Details)
84: R70 Subsequent Events (Details) HTML 24K
86: XML IDEA XML File -- Filing Summary XML 152K
85: EXCEL IDEA Workbook of Financial Reports XLSX 106K
9: EX-101.INS XBRL Instance -- pcrx-20151231 XML 2.71M
11: EX-101.CAL XBRL Calculations -- pcrx-20151231_cal XML 227K
12: EX-101.DEF XBRL Definitions -- pcrx-20151231_def XML 689K
13: EX-101.LAB XBRL Labels -- pcrx-20151231_lab XML 2.13M
14: EX-101.PRE XBRL Presentations -- pcrx-20151231_pre XML 1.10M
10: EX-101.SCH XBRL Schema -- pcrx-20151231 XSD 212K
87: ZIP XBRL Zipped Folder -- 0001628280-16-011728-xbrl Zip 285K
| Exhibit |
Date:
| /s/ JAMES SCIBETTA President and Chief Financial Officer (Principal Financial Officer) | |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/25/16 | 8-K | ||
| For Period end: | 12/31/15 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/29/24 Pacira BioSciences, Inc. 10-K 12/31/23 123:17M 2/28/23 Pacira BioSciences, Inc. 10-K 12/31/22 118:16M 2/28/22 Pacira BioSciences, Inc. 10-K 12/31/21 128:17M 3/01/21 Pacira BioSciences, Inc. 10-K 12/31/20 113:13M |